Related Experiment Video
Updated: Feb 26, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Persistent Hyperglycaemia and Transient Dysglycaemia in Tuberculosis: Evaluating the Bidirectional Interaction With
Augustine Asare Boadu1,2, Prince Asare1, Michelle Yeboah-Manu3
1Department of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Introduction:
Poor glycaemic control, indicated by a haemoglobin A1c (HbA1c) level of 7% or higher, increases the risk of active tuberculosis (TB) in patients with diabetes, while active TB can worsen glucose tolerance and insulin resistance, contributing to type-2 diabetes mellitus (DM) progression. The bidirectional relationship between TB and DM is well recognised, but the evolution of glycaemic status during TB treatment, particularly the distinction between transient and persistent dysglycaemia, is not well understood in high-burden settings.
Methods:
We conducted a prospective cohort study of 120 newly diagnosed pulmonary TB patients in Ghana, categorised as TB-Only (n = 66), TB with established DM on metformin (TB-DMt, n = 39), and TB with dysglycaemia not requiring pharmacological therapy (TB-DMnt, n = 15). HbA1c was measured at baseline, 3, 6 and 9 months.
Results:
TB-DMt patients were older, had higher BMI and persistently elevated HbA1c (p < 0.001). In contrast, TB-DMnt patients showed significant HbA1c decline during and after TB treatment, normalising by 6 months (p < 0.016). Most TB-Only patients maintained stable euglycaemia. Transient dysglycaemia resolved in TB-DMnt, while persistent hyperglycaemia was confined to those with pre-existing DM (TB-DMt).
Conclusion:
Routine HbA1c monitoring during TB therapy can distinguish transient dysglycaemia from true diabetes, supporting more precise risk stratification and tailored management of TB patients.
More Related Videos
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...